| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |